Establishing core outcome sets for gastrointestinal recovery in studies of postoperative ileus and small bowel obstruction: protocol for a nested methodological study.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
04 2020
Historique:
received: 26 08 2019
accepted: 08 10 2019
pubmed: 9 11 2019
medline: 19 8 2021
entrez: 9 11 2019
Statut: ppublish

Résumé

Gastrointestinal recovery describes the restoration of normal bowel function in patients with bowel disease. This may be prolonged in two common clinical settings: postoperative ileus and small bowel obstruction. Improving gastrointestinal recovery is a research priority but researchers are limited by variation in outcome reporting across clinical studies. This protocol describes the development of core outcome sets for gastrointestinal recovery in the contexts of postoperative ileus and small bowel obstruction. An international Steering Group consisting of patient and clinician representatives has been established. As overlap between clinical contexts is anticipated, both outcome sets will be co-developed and may be combined to form a common output with disease-specific domains. The development process will comprise three phases, including definition of outcomes relevant to postoperative ileus and small bowel obstruction from systematic literature reviews and nominal-group stakeholder discussions; online-facilitated Delphi surveys via international networks; and a consensus meeting to ratify the final output. A nested study will explore if the development of overlapping outcome sets can be rationalized. The final output will be registered with the Core Outcome Measures in Effectiveness Trials initiative. A multi-faceted, quality improvement campaign for the reporting of gastrointestinal recovery in clinical studies will be launched, targeting international professional and patient groups, charitable organizations and editorial committees. Success will be explored via an updated systematic review of outcomes 5 years after registration of the core outcome set.

Identifiants

pubmed: 31701620
doi: 10.1111/codi.14899
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-464

Informations de copyright

Colorectal Disease © 2019 The Association of Coloproctology of Great Britain and Ireland.

Références

Scarborough JE, Schumacher J, Kent KC, Heise CP, Greenberg CC. Associations of specific postoperative complications with outcomes after elective colon resection: a procedure-targeted approach toward surgical quality improvement. JAMA Surg 2017; 152: e164681.
Ray NF, Denton WG, Thamer M, Henderson SC, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998; 186: 1-9.
Stewart B, Khanduri P, McCord C et al. Global disease burden of conditions requiring emergency surgery. Br J Surg 2014; 101: e9-22.
Tiernan J, Cook A, Geh I et al. Use of a modified Delphi approach to develop research priorities for the Association of Coloproctology of Great Britain and Ireland. Colorectal Dis 2014; 16: 965-75.
Chapman SJ, Wells CI. Challenges in ileus research. Colorectal Dis 2018; 20: 639.
Chapman SJ, Thorpe G, Vallance AE et al. Systematic review of definitions and outcome measures for return of bowel function after gastrointestinal surgery. BJS Open 2018; 3: 1-10.
Mellor K, Hind D, Lee MJ. A systematic review of outcomes reported in small bowel obstruction research. J Surg Res 2018; 229: 41-50.
Williamson PR, Altman DG, Bagley H et al. The COMET handbook: version 1.0. Trials 2017; 18: 280.
Kirkham JJ, Davis K, Altman DG et al. Core Outcome Set- STAndards for Development: the COS-STAD recommendations. PLoS Med 2017; 14: e1002447.
Kirkham JJ, Gorst S, Altman DG et al. Core Outcome Set- STAndards for Reporting: the COS-STAR statement. PLoS Med 2016; 13: e1002148.
Guyatt GH, Oxman AD, Kunz R et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400.
Boers M, Kirwan JR, Gossec L et al. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0. J Rheumatol 2014; 41: 1025-30.
Lever J, Krzywinski M, Altman N. Points of significance: principal component analysis. Nat Methods 2017; 14: 641-42.
SAS Statistics. Principal component analysis. http://support.sas.com/publishing/pubcat/chaps/55129.pdf (accessed June 2019).
Comrey A, Lee H. A First Course in Factor Analysis, 2nd edn. London: Routledge, 1992.

Auteurs

S J Chapman (SJ)

Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.

M J Lee (MJ)

Academic Directorate of General Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.

S Blackwell (S)

Patient Representative, Liverpool, UK.

R Arnott (R)

Patient Representative, Green Templeton College, Oxford, UK.

R P G Ten Broek (RPG)

Department of Surgery, Radboud University Medical Center, Nijmegen, Netherlands.

C P Delaney (CP)

Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA.

N N Dudi-Venkata (NN)

Discipline of Surgery, Faculty of Health and Medical Science, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.

D Hind (D)

Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.

D G Jayne (DG)

Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.

K Mellor (K)

Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.

A Mishra (A)

Department of Surgery, Maulana Azad Medical College, New Delhi, India.

G O'Grady (G)

Department of Surgery, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand.

T Sammour (T)

Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

G Thorpe (G)

Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.

C I Wells (CI)

Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

A M Wolthuis (AM)

Department of Abdominal Surgery, University Hospital Leuven, Leuven, Belgium.

N S Fearnhead (NS)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH